Israel - heprea - Ministry of Health

novartis israel ltd - rituximab - תרכיז להכנת תמיסה לאינפוזיה - rituximab 10 mg / 1 ml - rituximab

Israel - heprea - Ministry of Health

eli lilly israel ltd - duloxetine as hydrochloride - capsules - duloxetine as hydrochloride 30 mg - duloxetine - duloxetine - - cymbalta is indicated for the treatment of major depressive episodes. - cymbalta is indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy. - cymbalta is indicated for the treatment of generalized anxiety disorder (gad).- cymbalta is indicated for the management of fibromyalgia.- cymbalta is indicated for the management of chronic muscoskeletal pain. this has been established is studies in patients with chronic low back pain and chronic pain due to osteoarthritis when other therapies have failed or are contra-indicated.

Israel - heprea - Ministry of Health

eli lilly israel ltd - duloxetine as hydrochloride - capsules - duloxetine as hydrochloride 60 mg - duloxetine - duloxetine - - cymbalta is indicated for the treatment of major depressive episodes. - cymbalta is indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy. - cymbalta is indicated for the treatment of generalized anxiety disorder (gad).- cymbalta is indicated for the management of fibromyalgia.- cymbalta is indicated for the management of chronic muscoskeletal pain. this has been established is studies in patients with chronic low back pain and chronic pain due to osteoarthritis when other therapies have failed or are contra-indicated..

Israel - heprea - Ministry of Health

teva pharmaceutical industries ltd, israel - duloxetine as hydrochloride - קפסולות - duloxetine as hydrochloride 60 mg - duloxetine

Israel - heprea - Ministry of Health

teva pharmaceutical industries ltd, israel - duloxetine as hydrochloride - קפסולות - duloxetine as hydrochloride 30 mg - duloxetine

Israel - heprea - Ministry of Health

glaxo smith kline (israel) ltd - ofatumumab 20 mg/ml - concentrate for solution for infusion - ofatumumab - treatment of chronic lymphocytic leukaemia (cll) in patients who are refractory to fludarabine and alemtuzumab

Israel - heprea - Ministry of Health

glaxo smith kline (israel) ltd - ofatumumab 20 mg/ml - concentrate for solution for infusion - ofatumumab - treatment of chronic lymphocytic leukaemia (cll) in patients who are refractory to fludarabine and alemtuzumab

Israel - heprea - Ministry of Health

dor pharmaceutical services ltd., israel - bendamustine hydrochloride - אבקה להכנת תמיסה מרוכזת לעירוי - bendamustine hydrochloride 100 mg/vial - bendamustine

Israel - heprea - Ministry of Health

astellas pharma international b.v., israel - bendamustine hydrochloride - אבקה להכנת תמיסה מרוכזת לעירוי - bendamustine hydrochloride 100 mg - bendamustine

Israel - heprea - Ministry of Health

dor pharmaceutical services ltd., israel - bendamustine hydrochloride - אבקה להכנת תמיסה מרוכזת לעירוי - bendamustine hydrochloride 25 mg/vial - bendamustine